How White was paid
$906,020 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|
| Marvin L. WhiteChief Executive Officer and President | $575,000 | $4,420 | $316,250 | $10,350 | $906,020 |
| Jeffrey G. LamotheExecutive Vice President and Chief Operating Officer | $480,000 | $1,914 | $216,000 | $10,350 | $708,264 |
| SoYoung KwonSenior Vice President, General Counsel, Business Development and Corporate Affairs | $450,000 | $1,322 | $180,000 | $10,350 | $641,672 |
What changed and why
- $906K$906,020 was CEO total compensation in 2024, up from $873,446 in 2023.
- $575K$575,000 was CEO salary in 2024, compared with $565,123 in 2023.
- 55%$316,250 was the CEO’s 2024 target bonus, equal to 55% of base salary.
- 72%72% of each executive’s corporate bonus weighting paid out, while individual performance weighting paid out at 100%.
- $4,420$4,420 was the CEO’s 2024 equity award value; executives received RSUs vesting over three years.
- 150%150% of compensation is the CEO’s severance entitlement upon qualifying termination without cause outside a change of control.
Other Aptevo Therapeutics proxy statements
- 2026 proxy statement
Marvin L. White paid $1.3M (+41% on the year).
Filed Jul 31, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.